Equity

Synopsys·Balance Sheet Statement·17 metrics

Breakdown

Metric	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Total liabilities and stockholders' equity	$11.6B	$13.1B	$13B	$23.8B	$48.2B	$48.2B	$47.2B	$46.9B
Total stockholders' equity	$7.7B	$9B	$9.3B	$9.9B	$27.6B	$28.3B	$30.5B	$30.5B
Additional paid-in capital	$1.2B	$1.2B	$1.1B	$1.2B	$18.5B	$18.6B	$20.6B	$20.6B
Retained earnings	$7.9B	$9B	$9.3B	$9.6B	$9.9B	$10.3B	$10.4B	$10.4B
Share Repurchase Authorization Limit	—	—	—	—	—	—	—	$1.7B
Share Repurchase Program - Amount Remaining	$194.3M	—	$194.3M	$194.3M	$194.3M	—	$194.3M	$1.7B
Common stock	—	—	—	—	—	400M	—	400M
Accumulated other comprehensive income (loss)	-$180.1M	-$180.4M	-$241.9M	-$240.1M	-$231.9M	-$232.4M	-$203.7M	-$244.1M
Treasury stock	$1.2B	$1B	$861M	$689M	$572.1M	$398.3M	$191.9M	$242.8M
Convertible Preferred Stock Authorized Shares	—	—	—	—	—	2M	—	2M
Noncontrolling interests	—	—	—	—	—	-$587K	—	-$1.1M
Unrealized Gains on Investments	—	—	—	—	—	$219K	—	$126K
Common Stock Par Value Per Share	—	—	—	—	—	$0.01	—	$0.01
Preferred Stock Par Value Per Share	—	—	—	—	—	$0.01	—	$0.01
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	$61K	$22K	$15K	$12K	$0	$0	$0	$0
Convertible Preferred Stock Outstanding Shares	—	—	—	—	—	0	—	0
Preferred stock	—	—	—	—	—	$0	—	$0